Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013
Dr. Sulaiman Al-habib Medical Services — FY2024 Earnings Presentation
35 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, Feb 25, 2025
Slide 1: FY 2024 Investor Presentation
FY 2024 Investor Presentation As of 25 February 2025
Slide 2: Disclaimer
DISCLAIMER Disclaimer and important information in relation to this presentation This presentation is for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investm
Slide 3: Presenting Team
PRESENTING TEAM Ziyad Al Dahami Faisal Al Nassar Esam Al Mashloum Head of Investor Relations and Treasury Chief Executive Officer Vice President, Finance FY 2024 Investor Presentation 3 February 2025
Slide 4: Agenda
Agenda Financial Performance Projects Update Operational Highlights Appendix #1 Summarized Financials Appendix #2 About HMG FY 2024 Investor Presentation 4 February 2025
Slide 5: Financial Performance
Financial Performance
Slide 6: Key Financial Highlights: FY 2024
KEY FINANCIAL HIGHLIGHTS: FY 2024 Gross profit 14.50% Gross profit Margin 2024 3,744.26 2024 33.43% 2023 3,270.05 2023 34.39% (Millions) EBITDA 17.58% EBITDA margin 2024 2,975.43 2024 26.57% 2023 2,530.60 2023 26.61% (Millions) Net income 13.16% Net income margin 2024 2,315.29 2024 20.67% 2023 2,046
Slide 7: Balance Sheet Highlight
BALANCE SHEET HIGHLIGHT Total Assets in Dec-24 20.56 billion vs 15.80 billion in Dec-23 ROE ROA Cash and 16.59% 14.06% 20.88% 20.24% Current 2024 33.90% 2024 12.74% bank liabilities 2023 33.10% 2023 14.42% Accounts 5.40% 4.45% receivable 4.12% Inventories 3.44% 1.71% 2.30% Other current ROCE Current
Slide 8: Leverage Levels
LEVERAGE LEVELS Total liabilities and equity million 120.00% Total Liabilities/Total Assets Total Liabilities/Equity 100.00% 2024 0.63x 2024 1.70x 2023 0.57x 2023 1.33x 80.00% 37.03% 42.83% 9,031.80 12,945.28 Debt / Equity Net Debt / EBITDA 60.00% 2024 1.08x 2024 1.79x 2023 0.77x 2023 1.04x 40.00% 6
Slide 9: Total Cash Dividends for Shareholders
TOTAL CASH DIVIDENDS FOR SHAREHOLDERS Declared Cash Dividends Declared Cash Dividends - Q4 2024 Current Capital 3.5 billion - 50.00 100.00 150.00 200.00 250.00 300.00 350.00 400.00 450.00 500.00 Q4 2024 1.23 per share 430.5mn 70.1% 1.23 Payout per share Number of Shares 350 million Q3 2024 1.20 per
Slide 10: Highlights: 2024 Patient Overview
HIGHLIGHTS: 2024 PATIENT OVERVIEW Revenue by type 73.3% 74.3% +7.4 m Patients served 2023 2024 From +6 m in 2023 Bed occupancy - overall 22.4% 21.4% 2.3% 1.8% 2.0% 2.5% 58% Insurance Cash Government Others FY 2024 Investor Presentation 10 February 2025
Slide 11: Projects Update
Projects Update FY 2024 Investor Presentation 11 February 2025
Slide 12: Projects Update
PROJECTS UPDATE Solidifying our market leadership through robust expansion plans and Sehat Al Hamra Hospital Sehat Al Kharj Hospital 140+ Al Muhammadiyah Hospital 350+ progressing our projects Ownership Ownership Expected Kharj Kharj Ownership Expected Jeddah 100% 100% Completion 100% Completion 202
Slide 13: ous ity
ous ity DR SULAIM) o-4 4 Lot |AN AL HABIB
Slide 14: Operational Highlights
Operational Highlights U44s JIU 4 2 N AL HABIB Xx fou aubilacgo20ll an igh
Slide 15: FY 2024 Highlights
FY 2024 HIGHLIGHTS Key Highlights HMG Mobile Application Interaction 24% Booked 21% New Facilities in 2024: HMG opened six new facilities throughout 2024 including Sahafa Hospital, Fayhaa Hospital, Women’s Health, expansion of Appointments Qassim outpatient clinics and two new medical centers in Bur
Slide 16: Medical Excellence
MEDICAL EXCELLENCE Creating the medical practitioners of the future and promoting health and well-being Research Center Continuous Medical Education Postgraduate Program 4 Journal issued 360+ Activities 590+ Hours 41 125+ research paper published Residency & Fellowship program in Riyadh and Khobar a
Slide 17: ESG Highlights, Engagement and Achievements in Investor Relations
ESG HIGHLIGHTS, ENGAGEMENT AND ACHIEVEMENTS IN INVESTOR RELATIONS ESG highlights Engagement with Investment Community 235+ Investors and analysts meetings 5 Attended conferences Established a partnership with the United Nations Global 330+ Individuals attended the meetings 4 Earnings calls Compact
Slide 18: Recognitions & Accreditations
RECOGNITIONS & ACCREDITATIONS HMG continues to receive recognitions and accreditations from organizations around the world in recognition of our service quality and standards FY 2024 Investor Presentation 18 February 2025
Slide 19: Our People
OUR PEOPLE We continue to attract and retain top talent People Physicians 24,000+ 60% female 36% 4,500+ 88% 15+ average years Employees 40% male Saudization Physicians Retention Rate Experience Staff ratio Physician Qualifications 85+ 120+ recruiting Nationalities offices across the globe Saudi 34%
Slide 20: Investment Proposition
INVESTMENT PROPOSITION Driving sustainable value creation for our stakeholders in the Kingdom and beyond Attractive Industry Adaptable Operating Fundamentals Model Experienced Leadership Solid Performance with Team with Proven Track Long-term Growth Record Potential Market Leader in Medical Excellen
Slide 21: Appendix #1: Summarized Financials
Appendix #1 Summarized Financials
Slide 22: Summary: Statement of Financial Position
SUMMARY: STATEMENT OF FINANCIAL POSITION As of 31 December 2024 million As of 31 December 2024 2023 Current Assets 5,319.44 4,137.83 Investments in associates and others 165.35 197.59 Investments in equity instruments – Sukuk 300.00 300.00 Property and Equipment 14,773.15 11,162.62 Total Assets 20,5
Slide 23: Summary: Income Statement
SUMMARY: INCOME STATEMENT For the year ended 31 December 2024 million 2024 2023 Change % Revenue 11,200.43 9,508.44 17.79% Cost of revenue (7,456.17) (6,238.39) 19.52% Gross profit 3,744.26 3,270.05 14.50% Selling and marketing expenses (495.73) (402.70) 23.10% General and administrative expenses (8
Slide 24: Summary: Cash Flow Statement
SUMMARY: CASH FLOW STATEMENT For the year ended 31 December 2024 million 2024 2023 Net cash from operating activities 2,970.40 3,244.15 Net cash used in investing activities (3,775.36) (3,486.63) Net cash from (used in) financing activities 1,075.28 115.87 Cash and cash equivalents at the beginning
Slide 25: Appendix #2: About HMG
Appendix #2 About HMG
Slide 26: Where We Operate
WHERE WE OPERATE HMG continues to elevate healthcare delivery and innovation across the Kingdom and the region. MAP KEY Hospitals Hospitals Medical Under Construction Centers Medical Operated Centers Contract Under Construction FY 2024 Investor Presentation 26 February 2025
Slide 27: Geographic Footprint (continued)
GEOGRAPHIC FOOTPRINT (continued) Our Riyadh Presence We continually seek to expand our footprint, enhance our service and create additional value for all our stakeholders. MAP KEY Hospitals Hospitals Medical Under Construction Centers HMG Urgent Head Academy Care Office
Slide 28: Our Strategy
OUR STRATEGY Our well-defined growth strategy enhanced by our core values Our Values Our Pillars Our Priorities Strengthening our core • Attract, develop and empower our people Drivers: Outcomes: • Rigorous quality & safety standards • Patient and customer • Care about patients, communities and the
Slide 29: Key Message
KEY MESSAGE Strategic pillars underpin our drive to deliver best-in-class healthcare services Best-in-class Catalysts for value creation Efficiency drivers • Regional integrated healthcare • Technology: Pioneer in healthcare • Efficient cash conversion cycle: provider with 25+ year track record tech
Slide 30: Business Model
BUSINESS MODEL An integrated model of care built for outstanding patient experience and outcomes WHAT HELPS US OUR KEY STRENGTHS WHAT WE DO ACHIEVE OUR GOALS Forefront of Technology and Patient and Customer Centricity for Modern Facilities and Innovation Exceptional Outcomes & Experience Comprehensi
Slide 31: Medical Excellence
MEDICAL EXCELLENCE Medical Operation Strategic Pillars Standardization of Care Patient Safety Working tirelessly to ensure that all services Enhancing the safety of our patients at every provided by HMG are standardized by meeting moment in their journey with HMG has widely acceptable international
Slide 32: Pioneer in Healthcare Technology
PIONEER IN HEALTHCARE TECHNOLOGY Better medical outcomes, exceptional patient experience, and advanced operational practices Tele-medicine Developing cutting edge technology HIS (VIDA) Tele-Cardiology (Nabad 24 program): Designed to 80 Vida implemented sites Pioneer in healthcare technology, award
Slide 33: Diverse Board of Directors
DIVERSE BOARD OF DIRECTORS Our success is driven by our people Non-Executives Executives Independents Dr. Sulaiman Al Habib Group Founder and Mr. Faisal Al Nassar Mr. Obaid Al Rasheed Chairman of the Board of Board member, Group CEO Vice-Chairman Directors and CFO Mr. Hesham Al Habib Board member an
Slide 34: Experienced Senior Management
EXPERIENCED SENIOR MANAGEMENT Highly experienced, high caliber management Mr. Faisal Al Nassar CEO & President CORE FUNCTIONS CORPORATE FUNCTIONS INDEPENDENT FUNCTIONS Dr. Abdulwahab Mr. Hesham Al Habib Al Abdulwahab Chief Business Mr. Esam Al Mashloum Eng. Abdullah Dr. Riyad Al Atiqi Chief Operatin
Slide 35: Thank you
Thank you Dr. Sulaiman Al Habib Medical Services Group Investor Relations Department Telephone: +966 11 525 9999 | Extension: 4919 Mobile: +966 50 338 2785 Email: investor.relations@drsulaimanalhabib.com IR Website: www.hmg.com FY 2024 Investor Presentation 35 February 2025
Dr. Sulaiman Al Habib Medical Services Group — FY2024 Earnings Presentation on 6ix